Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

AIM: To review the effectiveness of exercise as a therapy for nonalcoholic fatty liver disease
(NAFLD) and potential benefits in treating insulin resistance and atherosclerosis …

Background: This meta-analysis evaluates the overall effect of the non-pharmacological
intervention, aerobic exercise, upon serum liver enzymes levels, glucose metabolism and …

As exercise is now an established therapy for the management of non-alcoholic fatty liver
disease (NAFLD), recent investigations have sought to identify the optimal dose (type …

BACKGROUND & AIMS: Exercise is an integral component of lifestyle intervention aimed at
weight loss, but an independent benefit of exercise in NAFLD has also been suggested …

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver condition
worldwide, and is projected to become the leading cause for liver transplantation in the …

Abstract Purpose of Review Nonalcoholic fatty liver disease (NAFLD) is a leading cause of
global liver disease. Because current pharmacologic treatments are ineffective, lifestyle …

Sedentarism is the pandemic of modern times. It is associated with several medical
conditions including obesity, type 2 diabetes mellitus, cardiovascular diseases and also liver …

The increasing recognition that fatty liver plays a direct role in the pathogenesis of
cardiovascular and metabolic disease has resulted in significant research enquiry into the …

Background & Aims Exercise is a first-line therapy for patients with non-alcoholic fatty liver
disease (NAFLD). We sought to: 1) summarize effective aerobic and resistance exercise …